COMPLICATIONS DURING CLOFIBRATE TREATMENT OF NEPHROTIC-SYNDROME HYPERLIPOPROTEINÆMIA
- 9 September 1972
- journal article
- Published by Elsevier in The Lancet
- Vol. 300 (7776), 506-509
- https://doi.org/10.1016/s0140-6736(72)91905-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Plasma Protein and Lipid Pattern in the Nephrotic SyndromeActa Medica Scandinavica, 2009
- HYPERLIPOPROTEINÆMIAS IN NEPHROTIC SYNDROMEThe Lancet, 1971
- ISCHIEMIC HEART-DISEASE AS A COMPLICATION OF NEPHROTIC SYNDROMEThe Lancet, 1969
- Acute Muscular Syndrome Associated with Administration of ClofibrateNew England Journal of Medicine, 1968
- Clofibrate in PerspectiveNew England Journal of Medicine, 1968
- Ischemic Heart Disease, Atherosclerosis, and LongevityCirculation, 1966
- Risk Factors in Coronary Heart Disease: An Evaluation of Several Serum Lipids as Predictors of Coronary Heart Disease: The Framingham StudyAnnals of Internal Medicine, 1964
- EXPERIMENTAL EVALUATION OF AN ORALLY ACTIVE COMBINATION OF ANDROSTERONE WITH ETHYL CHLOROPHENOXYISOBUTYRATEThe Lancet, 1962
- SERUM LIPID AND LIPOPROTEIN ALTERATIONS IN NEPHROSISJournal of Clinical Investigation, 1960
- THE NATURE AND TREATMENT OF CHRONIC PARENCHYMATOUS NEPHRITIS (NEPHROSIS)JAMA, 1917